Ronald Hunt - Insider Trading & Ownership

Entity
Individual
Location
C/O Credit Suisse 1 St Boston Prv Eqy, 11 Madison Avenue, New York, New York
Summary
The estimated net worth of Ronald Hunt is at least $217 K dollars as of May 17, 2024. Ronald Hunt is the Director of Iterum Therapeutics plc and owns shares of Iterum Therapeutics plc (ITRM) stock worth about $156 K. Ronald Hunt is the Director, 10%+ Owner of Harpoon Therapeutics, Inc. and owns shares of Harpoon Therapeutics, Inc. (HARP) stock worth about $32.2 K. Ronald Hunt is the Director of Rallybio Corp and owns shares of Rallybio Corp (RLYB) stock worth about $29.2 K.
All Insider Reports
All Insider Reports

Ownership of Ronald Hunt

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ITRM Iterum Therapeutics plc Director $156 K Oct 1, 2023
HARP Harpoon Therapeutics, Inc. Director, 10%+ Owner $32.2 K Mar 8, 2024
RLYB Rallybio Corp Director $29.2 K May 15, 2024

Insider Transactions Reported by Ronald Hunt:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership